Johnson & Johnson Spin-off

Johnson & Johnson Spin-off
Case Code: FINC201
Case Length: 12 Pages
Period: 1996- 2021
Pub Date: 2023
Teaching Note: Available
Price: Rs.200
Organization: Johnson Corporation’s (J&J)
Industry: Healthcare and Services
Countries: United States
Themes: M&A, Corporate Restructuring
Johnson & Johnson Spin-off
Abstract Case Intro 1 Case Intro 2 Excerpts


On November 12, 2021, Johnson & Johnson Corporation (J&J), a US-based healthcare conglomerate, announced that the company was going to spin-off its consumer health business. The Spin-off was expected to complete by November 2023. As per the plan, J&J was going to split its business into two separate public companies. One company would deal with drugs and medical devices carrying the brand name of J&J, whereas the other company would deal with consumer health business carrying the brands like Neutrogena, Aveeno, Tylenol, Listerine, and Band-Aid. The new company’s name was going to be Kenvue. The name was inspired by the Scotland word ‘ken’, which was related to knowledge and ‘vue’ was related to sight..

Buy this case study (Please select any one of the payment options)

Price: Rs.200
Price: Rs.200
PayPal (5 USD)

Custom Search